Acetaminophen determination in low-dose pharmaceutical syrup by NIR spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 3, 2010, Pages 510-516

  Ziemons E ^a   Mantanus, J ^a   Lebrun, P ^a   Rozet, E ^a   Evrard, B ^a   Hubert, Ph ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acetaminophen; Liquid form; Low dose; Near infrared spectroscopy; Process analytical technology; Validation

Indexed keywords

PARACETAMOL;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG FORMULATION; LOW DRUG DOSE; NEAR INFRARED SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PREDICTION; PRIORITY JOURNAL; SYRUP; TEMPERATURE; VALIDATION STUDY;

ACETAMINOPHEN; CALIBRATION; LIMIT OF DETECTION; SPECTROSCOPY, NEAR-INFRARED;

EID: 77954862856     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.06.003     Document Type: Article

References (30)

1. United States Food and Drug Administration (FDA), Guidance for industry PAT-A framework for innovative pharmaceutical manufacturing and quality assurance, FDA, 2004.
2. Burns D.A., Ciurczak E.W. Handbook of Near-Infrared Analysis 2008, vol. 35. CRC Press, New York. 3rd ed.
3. Luypaert J., Massart D.L., Vander Heyden Y. Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta 2007, 72:865-883.
4. Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., Jent N. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies. J. Pharm. Biomed. Anal. 2007, 44:683-700.
5. Bodson C., Dewé W., Hubert Ph., Delattre L. Comparison of FT-NIR Transmission and UV-vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets containing riboflavin. J. Pharm. Biomed. Anal. 2006, 41:783-790.
6. Moes J.J., Ruijken M.M., Gout E., Frijlink H.W., Ugwoke M.I. Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements. Int. J. Pharm. 2008, 357:108-118.
7. Tabasi S.H., Moolchandani V., Fahmy R., Hoag S.W. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy. Int. J. Pharm. 2009, 382:1-6.
8. Li W., Bagnol L., Berman M., Chiarella R.A., Gerber M. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis. Int. J. Pharm. 2009, 380:49-54.
9. Rosa S.S., Barata P.A., Martins J.M., Menezes J.C. Development and validation of a method for active drug identification and content determination of ranitidine in pharmaceutical products using near-infrared reflectance spectroscopy: a parametric release approach. Talanta 2008, 75:725-733.
10. Mantanus J., Ziémons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert Ph. Active content determination of non-coated pharmaceutical pellets by near infrared spectroscopy: method development, validation and reliability evaluation. Talanta 2010, 80:1750-1757.
11. Mantanus J, Ziémons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert Ph. Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: method development, validation and reliability evaluation. Anal. Chim. Acta 2009, 642:186-192.
12. Rantanen J., Räsänen E., Antikainen O., Mannermaa J.-P., Yliruusi J. In-line moisture measurement during granulation with a four-wavelength near-infrared sensor: an evaluation of process-related variables and a development of non-linear calibration model. Chemom. Intell. Lab. Syst. 2001, 56:51-58.
13. Sandler N., Rantanen J., Heinämäki J., Römer M., Marvola M., Yliruusi J. Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS Pharm. Sci. Tech. 2005, 6. Article 26.
14. Blanco M., Cueva-Mestanza R., Peguero A. Controlling individual steps in the production process of paracetamol tablets by use of NIR spectroscopy. J. Pharm. Biomed. Anal. 2010, 51:797-804.
15. Eustaquio A., Blanco M., Jee R.D., Moffat A.C. Determination of paracetamol in intact tablets by use of near infrared transmittance spectroscopy. Anal. Chim. Acta 1999, 383:283-290.
16. Ito M., Suzuki T., Yada S., Nakagami H., Teramoto H., Yonemochi E., Terada K. Development of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets. J. Pharm. Biomed. Anal. 2010, 53:396-402.
17. Blanco M., Castillo M., Peinado A., Beneyto R. Determination of low analyte concentrations by near-infrared spectroscopy: effect of spectral pretreatments and estimation of multivariate detection limits. Anal. Chim. Acta 2007, 581:318-323.
18. Chalus P., Roggo Y., Walter S., Ulmschneider M. Near-infrared determination of active substance content in intact low-dosage tablets. Talanta 2005, 66:1294-1302.
19. International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for human Use, Topic Q2 (R1): validation of analytical procedures: Text and methodology, Geneva, 2005.
20. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q9: Quality Risk Management, Geneva, 2005.
21. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part I. J. Pharm. Biomed. Anal. 2004, 36:579-586.
22. Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part II. J. Pharm. Biomed. Anal. 2007, 45:70-81.
23. Bouabidi A., Rozet E., Fillet M., Ziemons E., Chapuzet E., Mertens B., Klinkenberg R., Ceccato A., Talbi M., Streel B., Bouklouze A., Boulanger B., Hubert Ph. Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept. J. Chromatogr. A 2010, 1217:3180-3192.
24. Acetaminophen Capsules, United States Pharmacopoeia USP32NF27, The United States Pharmacopeial Convention, Rockville, 2009, p. 1338-1390.
25. European Medicines Agency, Draft: guideline on the use of near infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations, EMEA/CHMP/CVMP/QWP/17760/2009 Rev 1.
26. (accessed 26.02.10). http://wiki.eigenvector.com/index.php?title=Using_Cross-Validation.
27. Analytical Methods Committee Uncertainty of measurement: implication of its use in the analytical science. Analyst 1995, 120:2303-2308.
28. Eurachem/Citac Guide Quantifying the Uncertainty in Analytical Measurement 2000, 2nd ed.
29. CB EA-4/16, EA guidelines on the expression of uncertainty in quantitative testing. 2004. http://www.european-accreditation.org/.
30. Marini R.D., Chiap P., Boulanger B., Rudaz S., Rozet E., Crommen J., Hubert Ph. LC method for the determination of R-timolol in a S-timolol maleate: validation of its ability to quantify and uncertainty assessment. Talanta 2006, 68:1166-1175.